Friday, 24 April 2015

A NEW DRUG SUCCESSFUL IN TREATING MICE WITH CHRONIC HEPATITIS B, HUMAN TRIAL ONGOING


An experimental Cancer drug has been used by Australian scientists to cure hundreds of mice suffering from chronic Hepatitis B. Human trials are currently ongoing and this drug could be used to cure diseases like HIV, drug resistant tuberculosis.
Marc Pellegrini  who led a team at Melbourne's Walter and Eliza Hall Institute, Australia's oldest medical research facility says,
"we were 100% successful in curing HBV (Hepatitis B Virus).
The team used Birinapant, a U.S. created cancer drug which has been tried on over 350 Americans but not yet on sale.
Quoting Pellegrini,
"Birinapant enabled the destruction of Hepatitis B infected liver cells while leaving normal cells unharmed. Excitingly when Birinapant was administered in combination with current antiviral drug entecavir, the infection was cleared twice as fast compared with birinapant alone. We are hopeful these promising results will be successful in human clinical trials which are currently underway in Melbourne,  Perth and Adelaide.

No comments:

Post a Comment